Nemaura Medical, Faz Chowdhury, sugarBEAT, BEATdiabetes, glucose sensor, glucose sensor for Type 2 d

KITLIVING

continued over

Early adopters

It's fair to say that Type 2 diabetes is being

picked up at an earlier stage as GPs

and even the general population are on

the look-out for it. Plus, there are more,

and more widely available, diagnostic

tools to diagnose the condition. The

team at Nemaura Medical has based it's

technoogy on the basis that there are

three forms of diabetes:

1. Prediabetes the impact of which cannot

be known as we do not know how many

people are living with it at this stage,

2. Type 2 diabetes, usually treated with

diet and tablets, with some also on insulin

(many inevitably end up on insulin, which

is not a failure, its simply that other noninsulin interventions

lose efficacy over time.

3. Type 1 diabetes, people who by

definition are injecting or infusing insulin to

stay alive.

Chowdhury himself has a personal

interest in the diabetes healthcare arena

as he has three members of his family

who have diabetes and he can attest to

the impact the diagnosis of diabetes has

on the broader family.

The management team at Nemaura

Medical along with various investors

assessed a selection of potential markets

to use their sensor technology and it

quickly became clear that in the area

of Type 2 diabetes care there is, as

Chowdhury says, "a vast pool of unmet

need." The company was actually

founded 13 years ago to look into drug

delivery but has evolved over time based

on both the technology's capabilities as

well as the need to address the fact that

Type 2 diabetes control is underserviced

at the moment.

He explains, "We expressly aimed

to create a device, a CGM, that made

monitoring easy while also generating

powerful data. The benefits of CGM

is that it generates a profile, not just a

snapshot, as with a blood test. You get

a line, very like a graph, and a wobbly

line could mean something is up, that

the reaction to glucose present in the

blood is compromised. Also, currently

people with Type 2 diabetes might only

be doing infrequent blood tests and may

test on a day where their levels happen

to be normal, whereas much of the time

they are abnormal. The way we monitor

people with Type 2 diabetes at the

moment means that most simply have no

ABOVE: A sugarBEAT sensor

worn on the arm, with data seen

on the smartphone app,

BEAT diabetes.

Index

  1. Page 0001
  2. Dexcom CGM, continuous glucose monitoring
  3. Page 0003
  4. Page 0004
  5. Abbott Freestyle Libre, Flash Glucose Monitoring
  6. Page 0006
  7. Medtronic Guardian Connect
  8. Page 0008
  9. Page 0009
  10. Page 0010
  11. BD, Becton Dickinson, injection technique, BD pen needles
  12. Page 0012
  13. Home test HbA1c, A1C Now Self-Check
  14. Page 0014
  15. Medtronic Minimed 670G hybrid closed loop insulin pump
  16. Page 0016
  17. Association of British Clinical Diabetologists, Diabetes Technology Network, Libre Flash education p
  18. Page 0018
  19. Page 0019
  20. Page 0020
  21. Page 0021
  22. NHS UK coronovirus information
  23. Second Nature lifestyle behaviour change
  24. Carbs & Cals, Chris Cheyette, Yello Balolia, Making Carbs Count
  25. Carbs & Cals, Chris Cheyette, Yello Balolia, Making Carbs Count
  26. Carbs & Cals, Chris Cheyette, Yello Balolia, Making Carbs Count
  27. Diabetes UK helpline
  28. Page 0028
  29. Page 0029
  30. Nemaura Medical, Faz Chowdhury, sugarBEAT, BEATdiabetes, glucose sensor, glucose sensor for Type 2 d
  31. Nemaura Medical, Faz Chowdhury, sugarBEAT, BEATdiabetes, glucose sensor, glucose sensor for Type 2 d
  32. Nemaura Medical, Faz Chowdhury, sugarBEAT, BEATdiabetes, glucose sensor, glucose sensor for Type 2 d
  33. Nemaura Medical, Faz Chowdhury, sugarBEAT, BEATdiabetes, glucose sensor, glucose sensor for Type 2 d
  34. Page 0034
  35. Page 0035
  36. Page 0036
  37. Page 0037
  38. Page 0038
  39. Omnipod Insulet insulin pump with insulin pods, podders
  40. Page 0040

Related Issues